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Abstract  
Various substituted 2-aryl-5-aminomethyl- and -5-thiomethyl-1,3,4-oxadiazoles were 
synthesized in high yields from the corresponding chloromethyl derivatives.  Selective oxidation 
of the sulfides into 5-sulfinylmethyl and 5-sulfonylmethyl-1,3,4-oxadiazoles by 
dimethyldioxirane under mild conditions was also demonstrated.  
  






Derivatives of 1,3,4-oxadiazole constitute an important family of heterocyclic compounds.1 
Since many of them display a remarkable biological activity, their synthesis and transformations 
have been received particular interest for a long time. The 2-aryl-5-(substituted methyl)-1,3,4-
oxadiazoles have been reported to show antibacterial,2,3 antifungal,4 analgesic and anti-
inflammatory5,6, and hypoglycemic3 activity. Their synthetic usefulness has also been 
demonstrated. The 2-azidomethyl-5-(4-chlorophenyl)-1,3,4-oxadiazole, as a 1,3-dipole, added 
efficiently to norbornene derivatives7 while 2-phenyl-5-[(2-pyridylium)methyl]-1,3,4-oxadiazole 
chloride was found to be a good nitrone precursor8. Liebscher and his coworkers reported 
diastereoselective side-chain alkylation of oxadiazoles by using a prolinolyl group as a chiral 
auxiliary9 and also the synthesis of bicyclic imidazoles carrying oxadiazolyl moiety.10 To prepare 
the corresponding substrates, nucleophilic substitution of 2-aryl-5-chloromethyl-1,3,4-
oxadiazoles have usually been applied.  
The most popular synthesis of 2,5-disubstituted-1,3,4-oxadiazole based on the thermal or 
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acid-catalysed cyclization of 1,2-diacylhydrazines1. Ring-closure usually proceeded in the 
presence of hot phosphorus oxychloride3,4,11 although an improved method by using 
triphenylphospine/carbon tetrachloride/triethylamine reagent was also reported recently.2 
Oxidative cyclization of aldehyde or ketone acylhydrazones1 and thermal acylation of 5-
substituted tetrazoles followed by nitrogen elimination12-14 also afford the desired derivatives, but 
these approaches have not been used for the synthesis of 2-aryl-5-chloromethyl-1,3,4-
oxadiazoles.  
Recently we have studied the preparation of 2-(alkylamino- or dialkylaminomethyl]- and 2-
hetarylthiomethyl-5-aryl-1,3,4-oxadiazoles and selected results of this project are presented in 
this contribution.  
 
 
Results and Discussion  
 
The starting materials 1-3 were synthesized from the corresponding aroyl hydrazides and 
chloroacetyl chloride according to a reported procedure4,15. From the various conditions of their 
nucleophilic substitution reported in the literature (2 equiv. of nucleophile in dioxane,5,6 1-1.2 
equiv. of nucleophile in methanol or ethanol solution in the presence of potassium carbonate3, 
sodium acetate4 or triethyl amine,9 1 equiv. of nucleophile and 1 equiv. of sodium hydride in 
DMF10, 1 equiv. of nucleophile and potassium carbonate in DMSO solution15), the last one was 
found to give the highest yields. The reaction of chloromethyl derivatives 1,2 with various 
amines or hetarenethiols and potassium carbonate in DMSO solution at room temperature gave 
the expected amines 4,5 and sulfides 6,7 in good yields in 4-6 hrs (Scheme 1). Surprisingly, no 
reaction was observed upon analogous treatment of 2-chloromethyl-5-(3,4,5-trimethoxyphenyl)-
1,3,4-oxadiazole (3) even at a longer reaction period. At higher temperatures the starting material 
was consumed but the expected product was not obtained. It is very likely that under these 
conditions the concurrent attack of the nucleophile(s) on the C-2, C-5 carbon atoms of the 
oxadiazole ring takes place which leads to ring cleavage. 1  
When sulfides 6b,7b were treated with dimethyldioxirane16 (DMD), the corresponding 
sulfoxides 8b,9b and sulfones 10b,11b were obtained in excellent yields depending on the 
amount of oxidizing agent used. Treatment of the sulfides with 2-4 equiv. of DMD resulted in 
the formation of sulfoxides, the synthesis of sulfones required a higher amount (5-8 equiv.) of 
oxidizing agent. The oxadiazole moiety remained intact (Scheme 1). The measured 
sulfoxide/sulfone ratio of the crude product in the synthesis of sulfoxides was higher than 9/1 
which indicates a good chemoselectivity for the attack of DMD on the sulfur atom of the sulfide 
unit. This reactivity pattern is characteristic of DMD oxidation although exceptional deviations 
have also been reported.17 It is noteworthy that a complete decomposition of the starting 6,7 
sulfides without the formation of considerable amount of any sulfoxide or sulfone was found in 
the attempted oxidation by hydrogen peroxide in acetic acid. Once again, these results 
demonstrate the synthetic value of DMD in oxygen transfer under mild and neutral conditions.  
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The structures of the obtained products were proven by spectroscopic methods. The 
characteristic1 C=N band (1616-1594 cm-1) of medium intensity and a medium-strong band at 
1025-1000 cm-1 were identified in each IR spectra, the latter could be attributed to the C-O-C 
vibration or heteroatom ring deformation of the oxadiazole ring.18 The presence of the 1,3,4-
oxadiazole unit was supported by the appearance of two quaternary signals (C-2, C-5) in the 
range δ = 162.5-166.6 ppm of their 13C NMR spectrum. The oxadiazole ring was found to exert a 
slight upfield shift (ca. -5 ppm) on the ipso-carbon of the 2-aryl group. In their MS spectra 5-
chloromethyl derivatives 1-3 and 5-thiomethyl derivatives 6,7 gave molecular ions of medium 
intensity and the base peak usually belonged to the corresponding acylium ions and nitrile radical 
ions which formed by the cleavage of  the heteroatom ring. Both of these have been reported as 
characteristic1 for this family. However, only very weak molecular ion were detected in the 
spectra of the aminomethyl derivatives 4,5 as the  ArCO fragment appeared as a peak of 
medium intensity and the base peak usually came from the amine side chain. The most important 
fragmentation pathways are shown by Scheme 2.  
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Experimental Section  
 
General Procedures. Dimethyldioxirane solution was prepared according to literature 
procedure19 and its peroxide content was determined iodometrically. Chromatographic 
separations were performed using silica gel (Merck, 70-230 mesh). Thin-layer chromatography 
was carried out on Macherey-Nagel precoated silica plate (0.25 mm layer thickness). Melting 
points were determined on a Boetius hot-stage apparatus and are uncorrected. 1H NMR and 13C 
NMR spectra were recorded with a Gemini 200 spectrometer in CDCl3 solution unless otherwise 
specified (internal standard TMS, δ = 0 ppm). Mass spectra were taken on a VG Trio-2 (EI,       
70 eV) apparatus. IR spectra were recorded with a Perkin-Elmer 283 instrument in KBr disks.  
2-Aryl-5-(chloromethyl)-1,3,4-oxadiazoles 1, 2, 3 were prepared by a direct reaction of aromatic 
acidhydrazides and ClCH2COCl according to the procedure of Vakula et al..15 
 
5-Chloromethyl-2-(4-chlorophenyl)-1,3,4-oxadiazole (1). Colourless needles, yield 67%, mp 
80.5-81 °C (PhMe–hexane) (lit.11 85 °C). IR: 3012, 2960, 1604 (C=N), 1481, 1410, 1255, 1092 
(Ar-Cl), 1011, 835, 735, 727 cm-1. 1H NMR (DMSO-d6): 5.15 (s, 2H, CH2), 7.70 (d, J = 8.7Hz, 
2H, 3',5'-H), 8.05 (d, J = 8.7, 2H, 2',6'-H). 13C NMR (DMSO-d6): 33.1 (CH2), 121.9 (C-1'), 128.7 
(C-2',6'), 129.9 (C-3',5'), 137.4 (C-4'), 163.3, 164.5 (C-2, C-5). MS: 228/230/232 (35/21/5, M+, 
Cl35/Cl37/2xCl37), 193 (28, M – Cl), 179 (10, M – CH2Cl), 139 (100, 4-ClC6H4CO+), 137 (29, 4-
ClC6H4CN), 123 (16), 111 (50, 4-ClC6H4+), 75(53).  
5-Chloromethyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (2). Colourless prisms, yield 61%, mp 
88.5-90 °C (PhMe–hexane) (lit. 11 94-95 °C, lit.19 92 oC). IR: 3018, 1616 (C=N), 1497, 1428, 
1310, 1259 (C-O-C), 1178, 1008, 843, 744, 737 cm-1. 1H NMR (DMSO-d6): 3.87 (s, 3H, MeO), 
5.12 (s, 2H, CH2), 7.15 (d, J = 9.0 Hz, 2H, 3',5'-H), 7.95 (d, J = 9.0 Hz, 2H, 2',6'-H). 13C NMR 
(DMSO-d6): 33.2 (CH2), 55.5 (MeO), 115.2 (C-3',5'), 115.3 (C-1'), 128.8 (C-2',6'), 162.6, 165.3 
(C-2, C-5, C-4'). MS: 224/226 (29/9, M+•, Cl35/Cl37), 189 (20, M – Cl), 135 (100, 4-
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MeOC6H4CO+), 133 (20, 4-MeOC6H4CN), 119 (8), 92 (15), 77 (23).  
5-Chloromethyl-2-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole (3). Colourless needles, yield 
68%, mp 106.5-110 °C (PhMe–hexane) (lit.15 215 °C). IR: 3008, 1594 (C=N), 1498, 1462, 1418, 
1322, 1240 (C-O-C, OMe), 1130 (C-O-C, OMe), 996, 846, 744, 728 cm-1. 1H NMR: 3.92 (s, 3H, 
4-OMe), 3.96 (s, 6H, 3,5-OMe), 4.80 (s, 2H, CH2), 7.90 (s, 2H, 2,6-H). 13C NMR: 32.9 (CH2), 
56.3 (3’,5’-MeO), 60.9 (4’-MeO), 104.3 (C-2’,6’), 118.2 (C-1’), 141.4 (C-4’), 153.6 (C-3’,5’), 
162.0, 165.8 (C-2, C-5). MS: 284/286 (48/16, M+•, Cl35/Cl37), 269 (20, M – Me), 249 (4, M – Cl), 
195 (100, (MeO) 3C6H2CO+).   
2-(4-(Chlorophenyl)-5-(tert-butylamino)methyl-1,3,4-oxadiazole (4a). Typical procedure. 
1.37 mL (13.037 mmol) of tert-butylamine and 1.86 g (13.5 mmol) of anhydrous K2CO3 were 
added to a stirred solution of 1 (1.498 g, 6.540 mmol) in DMSO (30 mL) at room temperature 
and the reaction was monitored by TLC (MeOH-PhMe = 10:1, v/v). After 4 hours it was poured 
into water (200 mL). The precipitate was filtered off and washed with hexane (2x10 mL) to 
obtain 1.165 g (67%) of 4a as white microcrystalline powder. mp 72.5-73.5 °C (EtOAc-hexane). 
IR: 3339 (NH), 2967 (CH3), 1607 (C=N), 1584, 1482, 1409, 1364, 1091 (Ar-Cl), 1010, 844, 729 
cm-1. 1H NMR: 1.19 (s, 9H, tBu), 1.51 (s, 1H, NH), 4.10 (s, 2H, CH2), 7.46 (d, J = 6.8 Hz, 2H, 
3',5'-H), 8.00 (d, J = 6.8 Hz, 2H, 2',6'-H). 13C NMR: 28.7 (CMe3), 37.8 (CH2), 51.0 (CMe3), 
122.5 (C-1'), 128.3 (C-2',6'), 129.5 (C-3',5'), 138.1 (C-4'), 164.4, 166.6 (C-2, C-5). MS: 250 (54, 
M – CH3), 193 (5, M – tBuNH), 181 (12), 139 (29, 4-ClC6H4CO+), 111 (15, 4-ClC6H4+), 95 (20), 
70 (100, C4H8N). Anal. Calcd. for C13H16ClN3O (265.74): C, 58.76; H, 6.07; N, 15.81. Found: C, 
58.77; H, 5.89; N, 15.44.  
5-(Benzylamino)methyl-2-(4-chlorophenyl)-1,3,4-oxadiazole (4b). From chloride 1          
(1.541 g, 6.727 mmol) and benzylamine (1.48 mL, 13.549 mmol) as given for 4a. Yield 86%, mp 
69.5-71 °C. IR: 3372 (NH), 2923, 1606 (C=N), 1484, 1453, 1412, 1412, 1133, 1097, (Ar-Cl), 
1016, 830, 742, 736 cm-1. 1H NMR: 1.90 (s, 1H, NH), 3.90 (s, 2H, PhCH2), 4.10 (s, 2H, 
HetCH2), 7.25-7.36 (m, 5H, Ph), 7.50 (d, J = 6.9 Hz, 2H, 3',5'-H), 7.96 (d, J = 6.9 Hz, 2H, 2',6'-
H). 13C NMR: 42.8 (HetCH2), 52.9 (PhCH2), 122.4 (C-1'), 127.5 (C-4"), 128.3, 128.4, 128.7, 
129.6 (C-2',6', C-3',5', C-2",6", C-3",5"), 138.2, 139.1 (C-4', C-1"), 164.5, 165.6 (C-2, C-5). MS: 
298 (<1, M – 1), 194 (20, M – PhCH=NH), 139 (10, 4-ClC6H4CO+), 137 (8, 4-ClC6H4CN), 106 
(100, PhCH2NH+), 91 (41, PhCH2+). Anal. Calcd. for C16H14ClN3O (299.75): C, 64.11; H, 4.71; 
N, 14.02. Found: C, 63.94; H, 4.58; N, 14.22.  
2-(4-Chlorophenyl)-5-(cyclohexylamino)methyl-1,3,4-oxadiazole (4c). From chloride 1               
(1.513 g, 6.605 mmol) and cyclohexylamine (1.52 mL, 13.287 mmol) as given for 4a. Yield 
94%, mp 82.5-85 °C. IR: 3310 (NH), 2930 (CH2), 2853, 1584, 1483, 1413, 1203, 1133, 1095 
(Ar-Cl), 1011, 855, 834, 732 cm-1. 1H NMR: 1.20 (m, 4H, cyclohexyl CH2), 1.70 (m, 4H, 
cyclohexyl CH2), 1.92 (m, 2H, cyclohexyl CH2), 3.56 (m, 1H, cyclohexyl CH), 4.12 (s, 2H, 
HetCH2), 7.50 (d, J = 8.7 Hz, 2H, 3',5'-H), 8.00 (d, J = 8.7 Hz, 2H, 2',6'-H). 13C NMR: 24.6 (C-
3",5"), 25.8 (C-4"), 33.0 (C-2',6"), 40.9 (HetCH2), 55.9 (C-1"), 122.5 (C-1'), 128.3, 129.6 (C-
2',6', C-3',5'), 138.1 (C-4'), 164.5, 166.1 (C-2, C-5). MS: 291 (<1, M+), 290 (<1, M – 1), 248 (10, 
M – C3H7), 194 (12), 139 (13, 4-ClC6H4CO+), 111 (6, 4-ClC6H4+), 98 (100, cHxNH+). Anal. 
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Calcd. for C15H18ClN3O (291.78): C, 61.75; H, 6.22; N, 14.40. Found: C, 61.85; H, 6.25; N, 
14.27.  
2-(4-Chlorophenyl)-5-[(2-pyrrolidinoethyl)amino]methyl-1,3,4-oxadiazole (4d). From 
chloride 1 (1.501 g, 6.553 mmol) and 1-(2-aminoethyl)pyrrolidine (1.65 mL, 13.019 mmol) as 
given for 4a. Yield 94%, mp 63.5-65 °C. IR: 3285 (NH), 2929, 1607 (C=N), 1559, 1488, 1411, 
1130, 1092 (Ar-Cl), 1001, 841, 818, 738 cm-1. 1H NMR: 1.75 (m, 4H, 3",4"-H), 2.15 (br s, 1H, 
NH), 2.50 (m, 4H, 2",5"-H), 2.62, 2.81 (2xt, J = 6.2 Hz, 2x2H, NHCH2CH2N), 4.12 (s, 2H, 
HetCH2), 7.50 (d, J = 8.6 Hz, 2H, 3',5'-H), 8.00 (d, J = 8.6 Hz, 2H, 2',6'-H). 13C NMR: 23.3 (C-
3',4"), 43.8 (HetCH2), 47.6 (NHCH2CH2N), 54.0 (C-2",5"), 55.4 (NHCH2CH2N), 122.5 (C-1'), 
128.3, 129.5 (C-2',6', C-3',5'), 138.1 (C-4'), 164.5, 165.8 (C-2, C-5). MS: 306 (<1, M+•), 194 (1), 
166 (1), 139 (5, 4-ClC6H4CO+), 84 (100, (CH2)4NCH2+). Anal. Calcd. for C15H19ClN4O (306.79): 
C, 58.72; H, 6.24; N, 18.26. Found: C, 58.79; H, 6.02; N, 17.99.  
2-(4-Chlorophenyl)-5-[(2-morpholinoethyl)amino]methyl-1,3,4-oxadiazole hydrochloride 
(4e.2HCl). From chloride 1 (1.508 g, 6.583 mmol) and 1-(2-aminoethyl)morpholine (1.70 mL, 
12.953 mmol) as given for 4a. The oily product was treated with saturated HCl solution in abs. 
diethyl ether to give 2.226 g (99%) of hydrochloride. Mp 205-208°C. IR: 2953 (CH2), 2666, 
2441, 2363 (NH+), 1611 (C=N), 1591, 1484, 1111, 1095 (Ar-Cl), 1012, 732 cm-1. 1H NMR 
(DMSO-d6: 3.40, 3.75, 3.92 (br m's, 15H, 6xCH2 + NH2++ NH+, 4.75 (s, 2H, HetCH2), 7.74 (d, J 
= 8.6 Hz, 2H, 3',5'-H), 8.09 (d, J = 8.6 Hz, 2H, 2',6'-H). 13C NMR (DMSO-d6: 51.5 (C-2",6"), 
51.6 (CH2-morpholino), 63.2 (C-3",5"), 122.0 (C-1'), 128.8, 130.0 (C-2',6', C-3',5'), 137.5 (C-4'), 
160.0, 164.5 (C-2, C-5). NHCH2 and HetCH2 overlapped with the DMSO signal. Anal. Calcd. 
for C15H21Cl3N4O2 (395.71): C, 45.53; H, 5.35; N, 14.16. Found: C, 45.00; H, 5.18; N, 13.79.  
2-(4-Chlorophenyl)-5-[(3-hydroxypropyl)amino]methyl-1,3,4-oxadiazole (4f). From chloride 
1 (1.501 g, 6.553 mmol) and 3-hydroxypropylamine (1.00 mL, 13.074 mmol) as given for 4a. 
Yield 85%, mp 95-96.5 °C. IR: 3250 (NH), 3154 (OH), 2932 (CH2), 2858, 1607 (C=N), 1485, 
1411, 1090 (Ar-Cl), 1067, 1012, 956, 913, 831, 731 cm-1. 1H NMR: 1.80 (m, 2H, 
NHCH2CH2CH2OH), 2.78 (br s, 2H, NH, OH), 2.95 (t, J = 5.9 Hz, 2H, NHCH2CH2CH2OH), 
3.82 (t, J = 5.9 Hz, 2H, NHCH2CH2CH2OH), 4.12 (s, 2H, HetCH2), 7.50 (d, J = 8.6 Hz, 2H, 
3',5'-H), 8.00 (d, J = 8.6 Hz, 2H, 2',6'-H). 13C NMR: 31.0 (NHCH2CH2CH2OH), 43.6 (HetCH2), 
48.3 (NHCH2CH2CH2OH), 62.9 (NHCH2CH2CH2OH), 122.3 (C-1'), 128.3, 129.6 (C-2',6', C-
3',5'), 138.3 (C-4'), 163.5, 165.3 (C-2, C-5). MS: 267 (2, M+•), 222 (10), 194 (22, M – 
CH2CH2OH), 139 (35, 4-ClC6H4CO+), 137 (16, 4-ClC6H4CN), 111 (12), 102 (5), 74 (100, 
+NHCH2CH2CH2OH). Anal. Calcd. for C12H14ClN3O2 (267.71): C, 53.84; H, 5.27; N, 15.70.  
5-(tert-Butylamino)methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (5a). From chloride 2 
(1.505 g, 6.670 mmol) and tert-butylamine (0.70 mL, 6.661 mmol) as given for 4a. Yield 57%, 
mp 75-77 °C. IR: 3316 (NH), 2970 (CH3), 1616 (C=N), 1591, 1502, 1426, 1363, 1307, 1259 (C-
O-C, OMe), 1185, 1085, 1025, 832, 740, 702 cm-1. 1H NMR: 1.15 (s, 9H, tBu), 3.85 (s, 3H, 
MeO), 4.01 (s, 2H, HetCH2), 6.95 (d, J = 8.9 Hz, 2H, 3',5'-H), 7.96 (d, J = 8.9 Hz, 2H, 2',6'-H). 
13C NMR: 28.7 (CMe3), 37.8 (HetCH2), 50.9 (CMe3), 55.3 (OMe), 114.5 (C-3',5'), 116.6 (C-1'), 
128.8 (C-2',6'), 162.5, 165.2, 165.8 (C-2, C-5, C-4'). MS: 261 (1, M+•), 246 (80, M – Me), 189 
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(53, M – tBuNH), 177 (13), 135 (100, 4-MeOC6H4CO+), 133 (29, 4-MeOC6H4CN), 92 (10), 77 
(16), 70 (56, C4H8N). Anal. Calcd. for C14H19N3O2 (261.32): C, 64.35; H, 7.33; N, 16.08. Found: 
C, 64.30; H, 7.48; N, 15.99.  
5-(Benzylamino)methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole hydrochloride (5b.HCl). 
From chloride 2 (1.508 g, 6.713 mmol) and benzylamine (0.74 mL, 6.774 mmol) as given for 4a. 
The oily product was treated with saturated HCl solution in abs. diethyl ether to give 1.447 g 
(65%) of hydrochloride. Mp 141-143 °C. IR: 2929, 2728, 2600 (NH+), 1616 (C=N), 1500, 1450, 
1308, 1255 (C-O-C, OMe), 1176, 1024, 844, 743, 701 cm-1. 1H NMR (DMSO-d6): 3.87 (s, 3H, 
OMe), 4.35 (s, 2H, PhCH2CH2), 4.59 (s, 1H, HetCH2), 7.19 (d, J = 8.9 Hz, 2H, 3',5'-H), 7.43 (m, 
3H, 2",4",6"-H), 7.59 (m, 2H, 3",5"-H), 7.98 (d, J = 8.9 Hz, 2H, 3',5'-H), 10.4 (br s, 2H, NH2+). 
13C NMR (DMSO-d6): 50.0, 55.6 (PhCH2CH2, HetCH2), 115.2 (C-3',5'), 115.4 (C-1'), 128.8 (C-
2',6' + C-3",5"), 129.3 (C-4")*, 130.6 (C-2",6"), 131.7 (C-1")*, 159.6, 162.6, 165.2 (C-2, C-5, C-
4'). *Interchangeable assignment. MS: 190 (60, 2-Ar-5-Me-1,3,4-oxadiazole), 135 (27, 4-
MeOC6H4CO+), 133 (30, 4-MeOC6H4CN), 106 (100, PhCH2NH), 91 (65, PhCH2), 77(16). Anal. 
Calcd. for C16H21N3O2 (287.36): C, 66.88; H, 7.37; N, 14.62. Found: C, 67.01; H, 7.17; N, 14.39.  
5-(Cyclohexylamino)methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (5c). From chloride 2 
(1.497 g, 6.664 mmol) and cyclohexylamine (0.77 mL, 6.731 mmol) as given for 4a. Yield 64%, 
mp 80-82.5 °C. IR: 3313 (NH), 2926 (CH2), 2851 (CH2), 1616 (C=N), 1504, 1426, 1309, 1256 
(C-O-C, OMe), 1181, 1086, 1032, 1005, 844, 740 cm-1. 1H NMR: 1.09-1.31 (m, 4H, cyclohexyl 
CH2), 1.62-1.98 (m, 6H, cyclohexyl CH2), 2.05 (m, 1H, NHCH), 3.92 (s, 3H, OMe), 4.12 (s, 2H, 
HetCH2), 7.01 (d, J = 9.0 Hz, 2H, 3',5'-H), 8.00 (d, J = 9.0 Hz, 2H, 2',6'-H). 13C NMR: 24.5 (C-
3",5"), 25.7 (C-4"), 32.9 (C-2",6"), 40.7 (HetCH2), 55.3, 55.8 (C-1", MeO), 114.5 (C-3',5'), 116.5 
(C-1'), 128.8 (C-2',6'), 162.5, 165.2 (C-2, C-5, C-4'). MS: 244 (2, M – C3H7), 224 (32), 189 (20), 
135 (100, 4-MeOC6H4CO+), 133 (22, 4-MeOC6H4CN), 119 (8), 92 (13), 77 (20). Anal. Calcd. 
for C16H21N3O2 (287.36): C, 66.88; H, 7.37; N, 14.62. Found: C, 66.95; H, 7.21; N, 14.55.  
2-(4-Methoxyphenyl)-5-[(2-pyrrolidinoethyl)amino]methyl-1,3,4-oxadiazole hydrochloride 
(5d.2HCl). From chloride 2 (1.498 g, 6.668 mmol) and 1-(2-aminoethyl)pyrrolidine (0.85 mL, 
6.707 mmol) as given for 4a. The oily product was treated with saturated HCl solution in abs. 
diethyl ether to give 1.047 g (46%) of hydrochloride. Mp 195-200 °C. IR: 2947 (CH2), 2924 
(CH2), 2675, 2600, 2363 (NH+), 1616 (C=N), 1500, 1260 (C-O-C, OMe), 1175, 1025, 841, 
741 m-1. 1H NMR (DMSO-d6): ~3.40 (br s, 3H, NH+, NH2+), 3.65, 3.86, 3.89 (3xs, 12H, CH2), 
4.74 (s, 2H, HetCH2), 7.22 (d, J = 8.8 Hz, 2H, 3',5'-H), 8.04 (d, J = 8.8 Hz, 2H, 2',6'-H). 13C 
NMR (DMSO-d6): 22.6 (C-3",4"), 42.7 (HetCH2), 49.2, 55.6 (NCH2CH2N), 53.2 (C-2",5"), 
115.2 (C-3',5'), 115.4 (C-1'), 128.9 (C-2',6'), 159.4, 162.7, 165.2 (C-2, C-5, C-4'). MS: 302 (1, 
M• of free base), 190(1), 135 (15, 4-MeOC6H4CO+), 111 (3), 84 (100, (CH2) 4NCH2+), 78 (38). 
Anal. Calcd. for C16H24Cl2N4O2 (375.29): C, 51.21; H, 6.45; N, 14.93. Found: C, 50.56; H, 6.41; 
N, 14.58.  
2-(4-Chlorophenyl)-5-[(2-pyridyl)thio]methyl-1,3,4-oxadiazole (6a). From chloride 1      
(1.506 g, 6.575 mmol) and 2-mercaptopyridine (0.734 g, 6.603 mmol) as given for 4a. Yield 
86%, mp 89-90.5 °C. IR: 2914, 1606 (C=N), 1578, 1558, 1483, 1456, 1412, 1256, 1130, 1092 
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(Ar-Cl), 1008, 834, 756, 733 cm-1. 1H NMR (DMSO-d6): 4.80 (s, 2H, HetCH2), 7.20 (dd, J = 7.3, 
5.2 Hz, 1H, 5"-H), 7.45 (d, J = 8.1 Hz, 1H, 3"-H), 7.70 (m, 3H, 3',5'-H), 7.94 (d, J = 8.6 Hz, 2H, 
2',6'-H), 8.43 (d, J = 5.8 Hz, 1H, 6"-H). 13C NMR (DMSO-d6): 22.7 (HetCH2), 120.9, 122.2 (C-
1', C-3", C-5"), 128.4, 129.9 (C-2',6', C-3',5), 137.0 (C-4'), 137.4 (C-4"), 149.8 (C-6"), 155.8 (C-
2"), 163.8, 165.0 (C-2, C-5). MS: 303/305 (63/21, M+•, Cl35/Cl37), 270 (6), 230 (8), 194 (6), 164 
(47), 139 (77, 4-ClC6H4CO+), 137 (43, 4-ClC6H4CN), 124 (75, 2-pySCH2+), 123 (100), 111 (83, 
2-pySH), 78 (80, py+). Anal. Calcd. for C14H10ClN3OS (303.76): C, 55.36; H, 3.32; N, 13.83. 
Found: C, 55.35; H, 3.11; N, 14.02.  
5-[(2-Benzimidazolyl)thio]methyl-2-(4-chlorophenyl)-1,3,4-oxadiazole (6b). From chloride 1 
(1.501 g, 6.553 mmol) and 2-mercaptobenzimidazol (0.985 g, 6.558 mmol) as given for 4a. 
Yield 86%, mp 205-206 °C. IR: 3073, 2985, 2881, 2811, 1609 (C=N), 1566, 1483, 1403, 1356, 
1280, 1092 (Ar-Cl), 1011, 834, 752, 724 cm-1. 1H NMR (DMSO-d6): 4.45 (s, 2H, HetCH2), 7.18 
(m, 2H, 5",6"-H), 7.50 (br s, 2H, 4",7"-H), 7.62 (d, J = 8.3 Hz, 2H, 3',5'-H), 7.90 (d, J = 8.3 Hz, 
2H, 2',6'-H), 12.80 (s, 1H, NH). 13C NMR: 25.3 (HetCH2), 122.2 (C-1'), 128.4, 129.8 (C-2',6', C-
3',5'), 137.0 (C-4'), 147.7 (C-2"), 163.9, 164.5 (C-2, C-5). C-4", C-3a", C-5", C-6", C-7", C-7a" 
carbon signals appeared as highly broadened singlets at δ ~ 111, 117.5, 122 ppm due to the 
exchange of hydrogen between the two nitrogens. MS: 342, 344 (43/15, Cl35/C377), 194 (26), 163 
(38, benzimidazolyl-SCH2+), 162 (80), 150 (90, 2-HS-benzimidazole), 139 (100, 4-ClC6H4CO+), 
123 (43), 111 (43, 4-ClC6H4+), 90 (15), 75(38). Anal. Calcd. for C16H11ClN4OS (342.80): C, 
56.06; H, 3.23; N, 16.34. Found: C, 55.97; H, 3.54; N, 16.20.  
5-[(2-Benzoxazolyl)thio]methyl-2-(4-chlorophenyl)-1,3,4-oxadiazole (6c). From chloride 1 
(1.515 g, 6.614 mmol) and 2-mercaptobenzoxazol (0.999 g, 6.608 mmol) as given for 4a. Yield 
84%, mp 105-106 °C. IR: 3084, 1606 w (C=N), 1586, 1502, 1486, 1453, 1403, 1238, 1224, 
1140, 1095 (Ar-Cl), 1009, 850, 754, 744, 731 cm-1. 1H NMR (DMSO-d2): 4.81 (s, 2H, HetCH2), 
7.32 (m, 2H, 5",6"-H), 7.46 (d, J = 8.5 Hz, 2H, 3',5'-H), 7.48, 7.65 (2xm, 2x1H, 4",7"-H), 7.92 
(d, J = 8.5 Hz, 2H, 2',6'-H). 13C NMR (DMSO-d6): 25.6 (HetCH2), 110.2 (C-7"), 119.0 (C-4"), 
122.0 (C-1'), 124.6, 124.8 (C-5",C-6"), 128.4, 129.6 (C-2',6', C-3',5'), 138.5 (C-4'), 141.8 (C-
3a"), 152.5 (C-7a"), 162.1, 162.9, 165.1 (C-2, C-5, C-2"). MS: 343/345 (35/12, M+•, Cl35/Cl37), 
270 (3), 193 (25), 151 (15, 2-HS-benzoxazole), 139 (100, 4-ClC6H4CO+), 123 (22), 111 (30, 4-
ClC6H4+), 91 (9), 75(15). Anal. Calcd. for C16H10ClN3O2S (343.78): C, 55.90; H, 2.93; N, 12.22. 
Found: C, 56.12; H, 2.77; N, 12.21.  
2-(4-Chlorophenyl)-5-[(1,2,4-triazol-3-yl)thio]methyl-1,3,4-oxadiazole (6d). From chloride 1 
(1.502 g, 6.557 mmol) and 3-mercapto-1,2,4-triazole (1.327 g, 13.122 mmol) as given for 4a. 
Yield 78%, mp 138.5-139 °C. IR: 3249 (NH), 3137, 1606 (C=N), 1565, 1484, 1460, 1410, 1274, 
1232, 1092 (Ar-Cl), 1012, 845, 729 cm-1. 1H NMR (DMSO-d6): 4.69 (s, 2H, HetCH2), 7.69 (d, J 
= 8.6 Hz, 2H, 3',5'-H), 7.98 (d, J = 8.6 Hz, 2H, 3',5'-H), 8.60 (s, 1H, triazole-H), 14.20 (br s, 1H, 
NH). 13C NMR (DMSO-d6): 25.4 (HetCH2), 122.2 (C-1'), 128.4, 129.9 (C-2',6', C-3',5'), 137.0 
(C-4'), 145.6 br (triazole CH), 163.8, 164.7 (C-2, C-5). MS: 293/295 (25/8, M+•, Cl35/Cl37), 193 
(8), 139 (100, 4-ClC6H4CO+), 113 (61), 111(61, 4-ClC6H4+), 75(40). Anal. Calcd. for 
C11H8ClN5OS (293.73): C, 44.98; H, 2.75; N, 23.84. Found: C, 45.21; H, 2.88; N, 23.44.  
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2-(4-Methoxyphenyl)-5-[(2-pyridyl)thio]methyl-1,3,4-oxadiazole (7a). From chloride 2  
(1.531 g, 6.815 mmol) and 2-mercaptopyridine (0.761 g, 6.845 mmol) as given for 4a. Yield 
84%, mp 49.5-51 °C. IR: 2999, 1615 (C=N), 1591, 1557, 1500, 1458, 1425, 1261 (C-O-C, 
OMe), 1130, 1086, 1029, 838, 756 cm-1. 1H NMR (DMSO-d6): 3.85 (s, 3H, OMe), 4.73 (s, 2H, 
HetCH2), 6.96 (d, J = 9.0 Hz, 2H, 3',5'-H), 7.06 (ddd, J = 7.1, 4.9, 1.0 Hz, 1H, 5"-H), 7.26 (dd, J 
= 8.2, 1.1 Hz, 1H, 3"-H), 7.54 (ddd, J = 8.2, 7.1, 1.9 Hz, 1H, 4"-H), 7.91 (d, J = 9.0 Hz, 2H, 2',6'-
H), 8.48 (dd, J = 4.9, 1.9 Hz, 1H, 6"-H). 13C NMR (DMSO-d6): 23.2 (HetCH2), 55.3 (OMe), 
114.5 (C-3',5'), 116.4 (C-1'), 120.4, 122.4 (C-3',5"), 128.7 (C-2',6'), 136.5 (C-4"), 149.7 (C-6"), 
156.0 (C-2"), 162.5, 163.8, 165.4 (C-2, C-5, C-4'). MS: 299 (56, M+•), 226 (10), 164 (25), 149 
(10), 135 (100, 4-MeOC6H4CO+), 124 (43, 2-pySCH2+), 123 (50), 111 (19, 2-pySH), 92 (26), 78 
(50, py+). Anal. Calcd. for C15H13N3O2S (299.34): C, 60.19; H, 4.38; N, 14.04. Found: C, 59.89; 
H, 4.29; N, 14.05.  
5-[(2-Benzimidazolyl)thio]methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (7b). From chloride 
2 (1.510 g, 6.722 mmol) and 2-mercaptobenzimidazole (1.011 g, 6.731 mmol) as given for 4a. 
Yield 89%, mp 199-203 °C. IR: 1616 (C=N), 1558, 1499, 1410, 1307, 1261 (C-O-C, OMe), 
1177, 1017, 1007, 843, 824, 735 cm-1. 1H NMR (DMSO-d6): 3.83 (s, 3H, OMe), 4.90 (s, 2H, 
HetCH2), 7.08 (d, J = 8.9 Hz, 1H, 3',5'-H), 7.15 (m, 2H, 5",6"-H), 7.43, 7.55 (2xbr s, 2x1H, 
4",7"-H), 7.81 (d, J = 8.9 Hz, 2H, 2',5'-H), 12.80 (s, 1H, NH). 13C NMR (DMSO-d6):  25.2 
(HetCH2), 55.4 (MeO), 110.8* (C-7"), 114.9 (C-3',5'), 115.7 (C-1'), 117.9* (C-4"), 121.6*, 
122.2* (C-5",6"), 128.4 (C-2',6'), 135.8*, 143.8* (C-3a",C-7a"), 147.7 (C-2"), 162.3, 163.5, 
164.6 (C-2, C-5, C-4'). Signals denoted with * slightly broadened due to the exchange of 
hydrogen between the two nitrogens. MS: 338 (20, M+), 190 (8), 189 (5), 163 (12, 
benzimidazolyl-SCH2+), 162 (20), 150 (19, 2-SH-benzimidazole), 135 (100, 4-MeOC6H4CO+), 
107(8, 4-MeOC6H4+), 92 (20), 77 (22). Anal. Calcd. for C17H14N4O2S (338.38): C, 60.34; H, 
4.17; N, 16.56. Found: C, 60.66; H, 3.99; N, 16.47.  
5-[(2-Benzothiazolyl)thio]methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (7e). From chloride 
2 (1.859 g, 8.275 mmol) and 2-mercaptobenzothiazole (1.390 g, 8.311 mmol) as given for 4a. 
Yield 76%, mp 88-92 °C. IR: 1613 (C=N), 1585, 1500, 1463, 1427, 1307, 1225 (C-O-C, OMe), 
1175, 1018, 997, 846, 755 cm-1. 1H NMR: 3.86 (s, 3H, OMe), 4.89 (s, 2H, HetCH2), 6.96 (d, J = 
9.0 Hz, 2H, 3',5'-H), 7.34, 7.46 (2xm, 2x1H, 5",6"-H), 7.79 (dd, J = 7.6, 1.5 Hz, 1H, 8"-H), 7.90 
(m, 3H, 2',6'-H, 4"-H). 13C NMR: 26.4 (HetCH2), 55.3 (OMe), 114.5 (C-3',5'), 116.1 (C-1'), 
121.2, 122.1, 124.9, 126.4 (C-4", C-5", C-6", C-7"), 128.8 (C-2',6'), 135.8 (C-7a"), 153.0 (C-2"), 
162.4, 162.7, 163.6, 165.7 (C-2, C-5, C-4', C-3a"). MS: 355 (12, M+•), 179 (8), 167 (15, 2-HS-
benzothiazole), 135 (100, 4-MeOC6H4CO+), 108 (10), 92 (10), 77 (12). Anal. Calcd. for 
C17H13N3O2S2 (355.42): C, 57.45; H, 3.69; N, 11.82. Found: C, 54.55; H, 3.34; N, 11.90.   
5-[(2-Benzimidazolyl)sulfinyl]methyl-2-(4-chlorophenyl)-1,3,4-oxadiazole (8b). Typical 
procedure. 21 mL of 0.074 M dimethyldioxirane solution in acetone (ca. 2.1 equiv.) was added 
to a solution of 6b (0.256 g, 0.747 mmol) in acetone (5 mL). The mixture was stirred for 30 
minutes at room temperature and monitored by TLC (MeOH-PhMe = 5:1, v/v).  After 
completion (30 min), the solvent was removed under reduced pressure to obtain 239 mg 
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yellowish crystalline solid which proved to be a 92/8 mixture of sulfoxide 8b and sulfone 10b by 
1H NMR analysis. The crude product was purified by column chromatography (hexane-Me2CO = 
1:1, v/v) to give 198 mg (74%) of pure 8b. mp 187-190 oC. IR: 3220 (NH), 2928, 1606 (C=N), 
1554, 1484, 1400, 1270, 1094 Ar-Cl), 1058, 1050 (S=O), 1012, 832, 746, 730 cm-1. 1H NMR 
(DMSO-d6): 4.94 (d, J = 14.1 Hz, 1H, one of HetCH2), 5.26 (d, J =14.1 Hz, 1H, the other 
HetCH2), 7.34 (m, 2H, 5",6"-H), 7.48 (A2B2, 4H, 2',3',5',6'-H), 7.65 (br s, 2H, 4",7"-H). MS: 358 
(70, M+), 284 (93), 282 (42), 240 (82, M – benzimidazole), 210 (100), 208 (58), 181 (19), 150 
(36, 2-HS-benzimidazole), 139 (69, 4-ClC6H4CO+), 111 (36, 4-ClC6H4+). Anal. Calcd. for 
C16H11ClN4O2S (358.80): C, 53.56; H, 3.09; N,  15.61. Found: C, 53.64; H, 2.99; N, 15.82.  
5-[(2-Benzimidazolyl)sulfinyl]methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (9b). From 
sulfide 7b (0.251 g, 0.742 mmol) with 61 mL 0.049 M dimethyldioxirane solution (ca. 4.0 
equiv.) according to the procedure given for 8b 0.247 g crude product (9b/11b = 9/1, 1H NMR) 
was obtained which yielded 0.197 mg (75%) pure 9b after column chromatography. mp 155-
158.3°C. IR: 2928, 1612 (C=N), 1498, 1428, 1402, 1306, 1260 (C-O-C, OMe), 1174, 1064 
(S=O), 1028, 838, 740 cm-1. 1H NMR (DMSO-d6): 3.80 (s, 3H, MeO), 4.91 (d, J = 13.9 Hz, 1H, 
one of HetCH2), 5.23 (d, J = 13.9 Hz, 1H, the other HetCH2), 6.94 (d, J = 8.4 Hz, 2H, 3',5'-H), 
7.34 (m, 2H, 5",6"-H), 7.41 (d, J = 8.4 Hz, 2H, 2',6'-H), 7.64 (br s, 2H, 4",7"-H). MS: 355 (5, M 
+ 1), 354 (2, M+•), 338 (1, M – O), 336 (2, M – H2O), 321 (3, M – H2O – Me), 237 (8), 190 (30), 
150 (37, 2-HS-benzimidazole), 135 (100, 4-MeOC6H4CO+), 133 (25, 4-MeOC6H4CN), 73 (35). 
Anal. Calcd. for C17H14N4O3S (354.38): C, 57.62; H, 3.98; N, 15.81. Found: C, 57.66; H, 4.15; 
N, 15.97.  
5-[(2-Benzimidazolyl)sulfonyl]methyl-2-(4-chlorophenyl)-1,3,4-oxadiazole (10b). From 
sulfide 6b (0.252 g, 0.732 mmol) with 58 mL 0.065 M dimethyldioxirane solution (ca. 5.2 
equiv.) according to the procedure given for 8b after removal of the solvent 0.247 g (90%) pure 
10b sulfone was obtained. mp 190-193.4°C. IR: 3088 (NH), 1608 (C=N), 1482, 1412, 1356, 
1344 (SO2), 1200, 1160, 1142 (SO2), 1094, 1012, 836, 806, 746 cm-1. 1H NMR (DMSO-d6): 5.68 
(s, 2H, HetCH2), 7.46 (br s, 2H, 5",6"-H), 7.58 (d, J = 8.4 Hz, 2H, 3',5'-H), 7.66 (d, J = 8.4 Hz, 
2H, 2',6'-H), 7.84 (br s, 2H, 4",7"-H). MS: 310, 312 (48/15, M – SO2, Cl35/Cl37), 268 (44), 194 
(16), 173 (56), 139 (100, 4-ClC6H4CO+), 111 (56, 4-ClC6H4+), 90 (35). Anal. Calcd. for 
C16H11ClN4O3S (374.80): C, 51.27; H, 2.96; N, 14.95. Found: C, 51.02; H, 3.13; N, 15.11.  
5-[(2-Benzimidazolyl)sulfonyl]methyl-2-(4-methoxyphenyl)-1,3,4-oxadiazole (11b). From 
sulfide 7b (0.252 g, 0.745 mmol) with 76 mL 0.079 M dimethyldioxirane solution (ca. 8.1 
equiv.) according to the procedure given for 8b after removal of the solvent 0.250 g (91%) pure 
11b sulfone was obtained. mp 192-194 °C. IR: 3082 (NH), 1614 (C=N), 1498, 1340 (SO2), 1262 
(C-O-C), 1186, 1176, 1144 (SO2), 1020, 1006, 840, 806, 742 cm-1. 1H NMR (DMSO-d6): 3.82 (s, 
3H, OMe), 5.64 (s, 2H, HetCH2), 7.02 (d, J = 9.1 Hz, 2H, 3',5'-H), 7.45 (m, 2H, 5",6"-H), 7.58 
(d, J = 9.1 Hz, 2H, 2',6'-H), 7.74 (br s, 2H, 4",7"-H). MS: 306 (31, M – SO2), 264 (24), 221 (45), 
189 (15), 173 (17), 157 (20), 135 (100, 4-MeOC2H6CO+), 118 (9), 81(40). Anal. Calcd. for 
C17H14N4O4S (370.38): C, 55.13; H, 3.81; N, 15.13. Found: C, 55.42; H, 3.85; N, 15.02.  
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